|
Hunley, T E; Kon, V (2001) Update on endothelins - biology and clinical implications. Pediatr Nephrol 16:752-62
|
|
Hunley, T E; Tamura, M; Stoneking, B J et al. (2000) The angiotensin type II receptor tonically inhibits angiotensin- converting enzyme in AT2 null mutant mice. Kidney Int 57:570-7
|
|
Hohenfellner, K; Hunley, T E; Yerkes, E et al. (1999) Angiotensin II, type 2 receptor in the development of vesico-ureteric reflux. BJU Int 83:318-22
|
|
Hohenfellner, K; Hunley, T E; Schloemer, C et al. (1999) Angiotensin type 2 receptor is important in the normal development of the ureter. Pediatr Nephrol 13:187-91
|
|
Gainer, J V; Hunley, T E; Kon, V et al. (1997) Angiotensin II type I receptor polymorphism in African Americans lower frequency of the C1166 variant. Biochem Mol Biol Int 43:227-31
|
|
Hunley, T E; Julian, B A; Phillips 3rd, J A et al. (1996) Angiotensin converting enzyme gene polymorphism: potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 49:571-7
|
|
Fogo, A; Kon, V (1996) Treatment of hypertension. Semin Nephrol 16:555-66
|
|
Iwasaki, S; Homma, T; Matsuda, Y et al. (1995) Endothelin receptor subtype B mediates autoinduction of endothelin-1 in rat mesangial cells. J Biol Chem 270:6997-7003
|
|
Kon, V; Hunley, T E; Fogo, A (1995) Combined antagonism of endothelin A/B receptors links endothelin to vasoconstriction whereas angiotensin II effects fibrosis. Studies in chronic cyclosporine nephrotoxicity in rats. Transplantation 60:89-95
|
|
Hunley, T E; Iwasaki, S; Homma, T et al. (1995) Nitric oxide and endothelin in pathophysiological settings. Pediatr Nephrol 9:235-44
|
Showing the most recent 10 out of 16 publications
